Abstract
Two patients had regression of basal cell carcinoma while receiving systemic chemotherapy for carcinoma of the lung, The chemotherapeutic agents with some efficacy in basal cell carcinoma are reviewed. Based on our patients and data from the literature, cisplatin appears to be a drug of potential usefulness in some patients with this neoplasm.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 306-310 |
| Number of pages | 5 |
| Journal | Journal of the American Academy of Dermatology |
| Volume | 18 |
| Issue number | 2 |
| DOIs | |
| State | Published - 1988 |
| Externally published | Yes |
ASJC Scopus subject areas
- Dermatology
Fingerprint
Dive into the research topics of 'Basal cell carcinoma: Response to systemic chemotherapy for lung carcinoma'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS